Hyper Corporation

Hyper Corporation Financial Leverage

The Financial Leverage (Equity Multiplier) of Hyper Corporation (065650.KQ) as of Nov 5, 2026 is 4.68. In the previous year, Financial Leverage (Equity Multiplier) was 3.45 — a change of 35.64% (higher).

Financial Leverage

4.68

YoY

35.64%

Last updated:

Financial Leverage (Equity Multiplier) of Hyper Corporation is 2025 4.68 . Financial Leverage (Equity Multiplier) of Hyper Corporation was 2024 3.45 . It decreases by 35.64% higher compared to the previous year.

The Hyper Corporation Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.12 KRW
Jan 1, 2019
1.10 KRW
Jan 1, 2020
1.70 KRW
Jan 1, 2021
1.16 KRW
Jan 1, 2022
1.79 KRW
Jan 1, 2023
1.51 KRW
Jan 1, 2024
3.45 KRW
Jan 1, 2025
4.68 KRW
The Hyper Corporation Financial Leverage history
YEARFinancial LeverageYoY
4.68+35.64%
3.45+128.41%
1.51-15.68%
1.79+54.46%
1.16-31.51%
1.70+54.09%
1.10-2.10%
1.12+5.97%
1.06-2.29%
1.09-16.25%
1.30+22.04%
1.06—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hyper Corporation Stock analysis

What does Hyper Corporation do? Hyper Corporation Inc generates revenue through the Information Technology Business segment, which manufactures and sells mouses, monitors, televisions, routers, and game devices, while also operating Internet portals and specialized sites. The New Drug Business segment develops and sells non narcotic analgesics, Alzheimer's treatments, and Alzheimer's dementia diagnosis kits. The company's IT products are purchased by consumers and businesses seeking technology solutions, while the pharmaceutical products target healthcare providers and patients requiring pain management and cognitive health support. The Information Technology Business segment benefits from the sale of hardware devices and digital content services, with Internet portals and specialized sites driving user engagement and advertising revenue. The New Drug Business segment focuses on medical solutions for chronic conditions, serving both institutional and individual markets through direct sales channels. Both segments operate under the same corporate structure, leveraging the company's existing infrastructure for product development and distribution. Hyper Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hyper Corporation stock

Financial Leverage (Equity Multiplier) of Hyper Corporation is 4.68 in 2025.

Financial Leverage (Equity Multiplier) of Hyper Corporation changed from 3.45 to 4.68, representing a 35.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Hyper Corporation since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Hyper Corporation with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Hyper Corporation

All Key Metrics — Hyper Corporation